What to Expect in Months 7-11 Essentially no side effects: Appetite suppression continues (desired effect), but GI symptoms gone Weight loss velocity slows: From 0.8kg/week (months 3-6) to 0.3-0.5kg/week Plateau around week 40-48: Weight stabilizes, no longer losing despite continued medication Total weight loss: Average 20-24% from baseline (matching or exceeding surgical outcomes) Focus shifts to maintenance: Accepting current weight, preventing regain Plateau frustration: Not a side effect but an emotional challenge 2 Final Strategies for Months 7-11 20
What the Published Data Shows Across the research literature, B12 deficiency rates after bariatric surgery fall in the following ranges (3): Roux-en-Y gastric bypass: approximately 2% to 80%, depending on follow-up duration and supplementation Sleeve gastrectomy: 0% to 36.4%, with deficiency often emerging up to two years post-surgery Biliopancreatic diversion with duodenal switch: highest rates, often requiring lifelong parenteral supplementation Weight loss medications: up to 2.6% incidence within one year of treatment These are wide ranges because research has pooled studies with very different follow-up windows and supplementation regimens
CPT 96372 RVU Components (2026 Estimates) RVU values are subject to geographic practice cost index (GPCI) adjustments by locality
Its important to know about the treatments different stages
The best of both NAD+ and Boost Me, our antioxidant booster
[DOI] [PubMed] [Google Scholar] 279.Flnes, I
